Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

Archive ouverte

Billa, Oumar | Chalouni, Mathieu | Salmon, Dominique | Poizot-Martin, Isabelle | Gilbert, Camille | Katlama, Christine | Neau, Didier | Chas, Julie | Morlat, Philippe | Lacombe, Karine | Naqvi, Alissa | Barange, Karl | Gervais, Anne | Bouchaud, Olivier | Rosenthal, Eric | Lascoux-Combe, Caroline | Garipuy, Daniel | Alric, Laurent | Domínguez, Stéphanie | Vittecoq, Daniel | Goujard, Cécile | Duvivier, Claudine | Aumaitre, Hugues | Miailhes, Patrick | Zucman, David | Simon, Anne | Lazaro, Estibaliz | Raffi, François | Esterle, Laure | Wittkop, Linda | Bani-Sadr, Firouze

Edité par CCSD ; Public Library of Science -

International audience. Compared to the general population, HIV-infected patients are at higher risk of developing non-AIDS-defining cancers. Chronic HCV infection has also been associated with a higher risk than that of the general population of developing cancers other than hepatocarcinoma. Evaluation of the impact of HCV-related factors on non-AIDS-defining and non HCV-liver (NANL) related cancers among HIV/HCV co-infected patients are scarce. The aim of this study was to identify the impact of HIV/HCV clinical characteristics on NANL related cancers in a large cohort of HIV/HCV-coinfected patients followed from 2005 to 2017. Cox proportional hazards models with delayed entry were used to estimate factors associated with NANL related cancer. Among 1391 patients followed for a median of 5 years, 60 patients developed NANL related cancers, yielding an incidence rate of 8.9 per 1000 person-years (95% CI, [6.6-11.1]). By final multivariable analysis, after adjustment for sex, tobacco or alcohol consumption, baseline CD4 cell count and HCV sustained viral response (SVR), age and a longer duration since HIV diagnosis were independently associated with a higher risk of NANL related cancer (aHR for each additional year 1.10, 95% CI 1.06-1.14, p<0.0001 and 1.06, 95% CI 1.01-1.11, p = 0.02, respectively). Duration of HCV infection, cirrhosis, HCV viral load, genotype and SVR were not associated with the occurrence of NANL related cancer. Among HIV/HCV-coinfected patients, age and the duration of HIV infection were the only characteristics found to be associated with the occurrence of NANL related cancer. In contrast, no association was observed with any HCV-related variables.

Suggestions

Du même auteur

Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus

Archive ouverte | Tan, Boun, Kim | CCSD

International audience. Background: An increased risk of cardiovascular disease (CVD) was reported in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), without identifying fact...

Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus

Archive ouverte | Tan, Boun Kim | CCSD

International audience. Abstract Background An increased risk of cardiovascular disease (CVD) was reported in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), without identify...

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort

Archive ouverte | Sogni, Philippe | CCSD

International audience. BACKGROUND:Human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients with cirrhosis have long been considered to be difficult to treat, and real-life efficacy and toleran...

Chargement des enrichissements...